Some of Silicon Valley’s most successful entrepreneurs and best technology minds have joined the crusade against ageing. Many are motivated by a personal experience with the diseases of ageing. Silicon Valley thrives on its ‘build fast and fail fast’ worldview, whereas health-care products and services are notoriously slow to develop, test and bring to market. How is the tech sector adapting to the pace of health care, and vice versa? Have the big names of technology – Brin, Thiel, Ellison and Gates – helped to put the longevity economy on the radar of policymakers and the broader community? Or, are the personal interests of entrepreneurial rock stars diverting healthcare priorities in this space? In this session we will find out how entrepreneurs can navigate the complex regulatory and ethical issues associated with innovating in health care. Lisa Suennen, managing director, GE Ventures David Sabow, head of life science and healthcare banking, Silicon Valley Bank Emily Melton, partner, DFJ